FORTRESS BIOTECH INC (FBIO)

Company Profile

Fortress Biotech Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Bay Harbor Islands, Florida and currently employs 187 full-time employees. The company went IPO on 2011-11-17. Fortress Biotech, Inc. is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. The firm markets its various branded dermatology products, Qbrexza, Accutane, Amzeeq, Zilxi, Ximino, Exelderm and Targadox. Qbrexza (glycopyrronium 2.4%) is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis in adults and children nine years and older. Accutane (isotretinoin) is an oral capsule for the treatment of severe recalcitrant nodular acne. Amzeeq (minocycline 4%) topical foam is a topical minocycline treatment for the inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and children nine years and older. Zilxi (minocycline 1.5%) is a topical foam and a topical minocycline treatment for inflammatory lesions of rosacea in adults. Ximino (minocycline hydrochloride) is an oral minocycline drug for the treatment of moderate to severe acne.

Company Info

FORTRESS BIOTECH INC

1111 Kane Concourse, Suite 301

Bay Harbor Islands FLORIDA 10014

P: 17816524500

CEO: Lindsay A. Rosenwald

Employees: 187

Website: https://www.fortressbiotech.com/